OXSONICS THERAPEUTICS
OxSonics® Therapeutics’ proprietary platform technology, SonoTran®, is being developed to provide a step-change in the therapeutic index of anti-cancer agents without the development costs or delays associated with drug reformulation. SonoTran is designed to increase the dose and distribution of anti-cancer agents within solid tumours, thereby increasing the efficacy and/or reducing the toxicity of these agents across the majority of the most challenging solid tumour cancers. The approach ha... s been specifically designed to fit seamlessly into existing oncology clinical workflows, and has the major advantage of enabling healthcare professionals to see-as-they-treat by providing visualisation on-screen and in real time. The SonoTran drug delivery platform is based on ground-breaking technological advances, originally invented at the University of Oxford’s Institute of Biomedical Engineering. OxSonics is based in Oxford in the UK. For more information please visit: www.oxsonics.com.
OXSONICS THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Device
Founded:
2013-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxsonics.com
Total Employee:
11+
Status:
Active
Contact:
+4401865784777
Total Funding:
24.7 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
Airify
Airify is a crowd-sourcing platform for air quality data.
Bicycle Therapeutics
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Chronolife
Chronolife builds predictive medical solutions to aid in diagnosis through a wireless, wearable technology.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Instylla
Instylla’s focus is to leverage hydrogel technology .
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Oxford Technology Management
Oxford Technology Management investment in Series B - OxSonics Therapeutics
Perivoli Innovations
Perivoli Innovations investment in Series B - OxSonics Therapeutics
Winton Ventures
Winton Ventures investment in Series B - OxSonics Therapeutics
ForumOxford (at the University of Oxford)
ForumOxford (at the University of Oxford) investment in Series B - OxSonics Therapeutics
Longwall Venture Partners
Longwall Venture Partners investment in Series B - OxSonics Therapeutics
Innovate UK
Innovate UK investment in Grant - OxSonics Therapeutics
Official Site Inspections
http://www.oxsonics.com
- Host name: 5.207.195.35.bc.googleusercontent.com
- IP address: 35.195.207.5
- Location:
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
More informations about "OxSonics Therapeutics"
About us - OxSonics Therapeutics
Cliff joined OxSonics as Principal Scientist in April 2015 to work on in-house development programs and co-development projects with strategic partners. Dr Calum Crake has over 12 … See details»
OxSonics Therapeutics - Crunchbase Company Profile …
OxSonics® Therapeutics’ proprietary platform technology, SonoTran®, is being developed to provide a step-change in the therapeutic index of anti-cancer … See details»
Company Profile: OxSonics Therapeutics - Focused Ultrasound …
Jan 13, 2022 Key Points OxSonics Therapeutics is a clinical-stage oncology company that has developed an ultrasound-based drug delivery platform. Their SonoTran Platform uses low … See details»
OxSonics Therapeutics - Leadership Team | The Org
The Leadership Team at OxSonics Therapeutics is responsible for setting the strategic direction of the company, overseeing the development and commercialization of the SonoTran® … See details»
OxSonics - 2025 Company Profile - Tracxn
Mar 23, 2025 OxSonics is a series B company based in Oxford (United Kingdom), founded in 2013 by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello. It operates … See details»
OXSONICS LIMITED overview - Find and update company …
OXSONICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity See details»
OxSonics Therapeutics Ltd - VentureRadar
OxSonics' SonoTran has the capability to maximise the therapeutic efficacy of unmodified solid tumour cancer drugs. SonoTran exploits a purely mechanical, drug-class-agnostic effect to … See details»
OxSonics Therapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for OxSonics Therapeutics. Use the PitchBook Platform to explore the full profile. See details»
Home - OxSonics Therapeutics
We’re OxSonics, a pioneering clinical-stage therapeutics company committed to developing a ground-breaking platform technology to make anti-cancer drugs smarter, act faster and, above … See details»
OxSonics - Oxford Investment Consultants portfolio Biotech …
OxSonics Therapeutics was spun out from the Institute of Biomedical Engineering at the University of Oxford in 2014. The Company’s proprietary platform technology, SonoTran ®, is … See details»
OxSonics Therapeutics is pleased to announce the appointment
OxSonics Therapeutics is pleased to announce the appointment of Jérome Marzinski, MBA as its new CEO. Please see the following press release for more details: https://lnkd.in/eWR8ucEF … See details»
OxSonics - Team members, CEO, Employees
Who are the key team members of OxSonics? OxSonics has 24 key team members. Who is the CEO of OxSonics? See details»
OxSonics Therapeutics - Funding, Financials, Valuation & Investors
OxSonics Therapeutics is funded by 6 investors. Oxford Technology Management and Perivoli Innovations are the most recent investors. Which investors participated in the most funding … See details»
Jérôme Marzinski Appointed as Chief Executive Officer
Nov 7, 2022 Jérôme Marzinski, Chief Executive Officer of OxSonics, said: “I am excited by the opportunity to lead OxSonics. I have been very impressed by both the calibre of the team and … See details»
SonoTran® Platform - OxSonics Therapeutics
OxSonics plans to provide an installed base of SonoTran ® Systems alongside the provision of training and service and maintenance of Systems. This allows our strategic partners to focus … See details»
OxSonics Ltd. (OxSonics Ltd.) - 药物管线_专利_临床试验_投融营收_ …
May 7, 2025 OxSonics Therapeutics Jérôme Marzinski assumed the position of chief executive officer of U.K.-based OxSonics. Marzinski is an independent board member of Cimon Medical, … See details»
Jérôme Marzinski Appointed as Chief Executive Officer
Nov 7, 2022 Seasoned medtech leader with a proven track record in scaling companies OXFORD, UK, November 07, 2022 / B3C newswire / -- OxSonics Therapeutics, a clinical … See details»
Jérôme Marzinski appointed as Chief Executive Officer - OxSonics ...
Nov 7, 2022 Seasoned medtech leader with a proven track record in scaling companies Oxford, UK – 7 November 2022 – OxSonics Therapeutics, a clinical-stage company focused on … See details»
OxSonics Therapeutics - Contacts, Employees, Board Members, …
OxSonics Therapeutics has 3 current employee profiles, including Co-Founder and Chief Technology Officer Christian Coviello. OxSonics Therapeutics has 2 board members and … See details»
Nicholas Adams Joins OxSonics as Chief Business Officer
Aug 10, 2020 Nicholas Adams Joins OxSonics as Chief Business Officer Oxford, UK – 5th August 2020 – OxSonics Therapeutics, a world leader in the development of ultrasound-based … See details»